Objectives: To develop the European League Against Rheumatism (EULAR) recommendations
for conducting clinical studies and/or clinical trials in systemic vasculitis. Methods: An …

Objectives: We undertook a systematic literature review as a background to the European
League Against Rheumatism (EULAR) recommendations for conducting clinical trials in anti-…

Nomenclature of Cutaneous Vasculitis Page 1 SPECIAL ARTICLE Nomenclature of
Cutaneous Vasculitis Dermatologic Addendum to the 2012 Revised International Chapel Hill …

Background Cyclophosphamide induction regimens for antineutrophil cytoplasmic antibody
(ANCA)–associated vasculitis are effective in 70 to 90% of patients, but they are associated …

… Luqmani has received consulting fees of less than $10,000 from Roche, Wyeth, Sanofi …
Luqmani has received consulting fees of less than $10,000 from Roche, Wyeth, Sanofi Winthrop, …

Objective To develop and validate revised classification criteria for granulomatosis with
polyangiitis (GPA). Methods Patients with vasculitis or comparator diseases were recruited into …

Objective To develop and validate revised classification criteria for eosinophilic granulomatosis
with polyangiitis (EGPA). Methods Patients with vasculitis or comparator diseases were …

Objectives: To develop European League Against Rheumatism (EULAR) recommendations
for the management of small and medium vessel vasculitis. Methods: An expert group (…

Objective To develop and validate classification criteria for microscopic polyangiitis (MPA).
Methods Patients with vasculitis or comparator diseases were recruited into an international …

Background Since the publication of the European League Against Rheumatism (EULAR)
recommendations for the management of large vessel vasculitis (LVV) in 2009, several …